Novel terpene-enriched therapeutic platform
An innovative, non-generic therapeutic platform comprising proprietary cannabinoid–terpene formulations designed through scientific optimization of cannabinoid–terpene interactions. The platform is supported by peer-reviewed research and protected by product patents.
Terpene-enriched cannabinoid composition
A proprietary terpene-enhanced cannabinoid formulation, comprising cannabinoids and carefully selected terpenes in optimized ratios, for the treatment of pain, sleep disorders, anxiety and depression. The standardized, innovative formulation is designed to leverage cannabinoid–terpene interactions and provide a versatile therapeutic platform.
Scope by jurisdiction: the European grant extends the indications to Autism Spectrum Disorder (ASD); the Canadian grant covers both cannabis flower and extract-based products and a large number of indications, including Alzheimer’s disease, post-traumatic stress disorder (PTSD), Parkinson’s disease and Tourette syndrome.
Inventors Aharon M. Eyal, Noa Raz
Terpene-enriched cannabinoid composition and method of treatment
A proprietary terpene-enhanced cannabinoid formulation comprising cannabinoids and carefully selected terpenes in optimized ratios. The innovative formulation encompasses both cannabis flower and extract-based products in a wide range of dosage forms, and leverages cannabinoid–terpene interactions through standardized compositions, providing a versatile therapeutic platform.
Inventors Noa Raz, Aharon M. Eyal
Isolated or synthetic cannabinoid compositions with selected terpene blend and methods of use thereof
A proprietary terpene-enhanced cannabinoid formulation comprising biosynthetically produced cannabinoids and carefully selected terpenes in optimized ratios. The technology combines synthetic or biologically produced cannabinoids with terpene enrichment to enhance therapeutic activity, providing a versatile platform for the development of next-generation cannabinoid-based therapeutics.
Inventors Noa Raz, Aharon M. Eyal
Terpene-enriched cannabinoid compositions and uses thereof in the treatment of infectious conditions
A proprietary terpene-enhanced cannabinoid formulation, comprising cannabinoids and carefully selected terpenes in optimized ratios, for treating conditions of the dermis and/or oral cavity, including ulcers, bacterial, viral, fungal or yeast infection, periodontal disease and psoriasis. The standardized, innovative formulation is designed to leverage cannabinoid–terpene interactions and provide a versatile therapeutic platform.
Inventors Noa Raz, Aharon M. Eyal
Terpene-enriched cannabinoid composition and method of treatment for treating conditions and/or symptoms associated with autism spectrum disorder
A proprietary terpene-enhanced cannabinoid formulation, comprising cannabinoids and carefully selected terpenes in optimized ratios, for treating conditions and symptoms associated with Autism Spectrum Disorder (ASD). The standardized, innovative formulation is designed to leverage cannabinoid–terpene interactions.
Inventors Noa Raz, Dana Berneman Zeitouni, Iso Heller, Aharon M. Eyal
Therapeutic formulations for specific populations
Novel composition patents directed at specific patient populations and clinical needs.
Terpene-enriched cannabinoid product for women’s health
A proprietary terpene-enriched cannabinoid formulation comprising cannabinoids, carefully selected terpenes and optional phytoestrogens in defined compositions for women’s health. The standardized formulation is designed to enhance therapeutic efficacy through optimized cannabinoid–terpene combinations, and provides a versatile platform for the treatment of perimenopause, menopause, menstrual and hormonal disorders, and female urogenital and reproductive conditions.
Inventors Noa Raz, Aharon M. Eyal
Terpene-enriched cannabinoid composition for treatment of male subjects
A proprietary terpene-enriched cannabinoid formulation comprising cannabinoids and carefully selected terpenes in defined compositions for men’s health. The standardized formulation is designed to enhance therapeutic efficacy through optimized cannabinoid–terpene combinations, and provides a versatile platform for the treatment of androgen deficiency, infertility, and urogenital or reproductive system infections and disorders.
Inventors Noa Raz, Aharon M. Eyal, Carmi Raz
Novel cannabis compositions
Novel compositions, including ones that are not attainable by genetic development, and methods for their industrial manufacture.
New cannabis compositions and industrial methods for production thereof
A proprietary standardized cannabis plant formulation comprising predefined THC and CBD ratios in a highly homogeneous composition. The platform enables the generation of compositions that are not naturally present in the cannabis plant, delivering consistent cannabinoid content in every dose, for pharmaceutical-grade products with reproducible performance, reliable dosing and broad applicability across inhalation and other dosage forms.
Inventor Aharon M. Eyal
Cannabis products and industrial methods for production thereof
A proprietary homogeneous cannabis plant formulation comprising standardized cannabis plant material with highly consistent cannabinoid content throughout the composition. By delivering reproducible potency in every portion, the formulation enables reliable dosing and supports the development of pharmaceutical-grade inhalation-based cannabis products.
Inventors Aharon M. Eyal, Meir Ariel, Yuri Shadurin, Looz Milay
Purified cannabis extracts and methods for production thereof
A manufacturing process for producing cleaner, higher-quality cannabis extracts. The invention uses a controlled extraction with ethanol or isopropanol, followed by the addition of a defined amount of water, which causes unwanted plant impurities to precipitate while keeping cannabinoids dissolved. The method improves extract purity, simplifies downstream processing and enhances consistency for pharmaceutical, medical cannabis and wellness products, without requiring complex purification technologies.
Inventors Aharon M. Eyal, Dana Berneman Zeitouni
Methods to create various cannabis product compounds
Granted in the United States as “Methods for the production of different cannabis product compositions”
A proprietary manufacturing technology that enables multiple standardized cannabinoid formulations with distinct cannabinoid–terpene profiles to be produced from a single batch of cannabis biomass. The process maximizes the value of raw plant material while creating differentiated products tailored for diverse therapeutic and commercial applications.
Inventor Aharon M. Eyal
Cannabidiol-enhanced probiotic compositions and uses thereof for treatment of infections
A proprietary formulation combining probiotic bacteria with cannabidiol (CBD) for the treatment and prevention of fungal infections. The formulation is designed for use in areas such as the vagina, oral cavity, skin and nails, where the probiotics and CBD may work together to restore microbial balance and support the body’s natural defenses against fungal pathogens.
Inventors Aharon M. Eyal, Noa Raz
Methods for drying and sterilization of cannabis material
A proprietary controlled post-harvest process for drying and sterilizing cannabis while carefully managing moisture content throughout production. The method combines gentle low-temperature drying, sterilization and final moisture adjustment to achieve an optimal water content in the finished plant material.
Inventors Aharon M. Eyal, Meir Ariel
Novel therapeutic formats
Cannabinoid formulations built on non-standard carriers and processing routes, creating stable oral formats with distinct bioactive profiles.
Therapeutic composition of cannabinoid and honey
Granted in the United States and Canada as “Honey-cannabinoid therapeutic composition”
A proprietary honey-based cannabinoid formulation that combines the natural properties of honey with low-dose cannabinoids in a stable, homogeneous composition. The formulation is designed to preserve cannabinoid potency, extend shelf life and provide a convenient oral platform for therapeutic and wellness applications.
Inventor Aharon M. Eyal
Therapeutic composition containing enzyme-rich cannabis
Granted in the United States and Canada as “Cannabis-enriched enzymatically treated therapeutic composition”
A proprietary enzyme-treated cannabinoid formulation comprising cannabinoids together with naturally generated bioactive reaction products in a stable, standardized composition. The formulation provides a novel therapeutic platform designed to support the development of next-generation cannabinoid formulations for neurological, psychiatric, inflammatory and pain-related disorders. The family protects the formulation itself, the method of treating disorders with it, and the method of its production.
Inventor Aharon M. Eyal
Delivery & dosing technologies
New formulations for cannabis product delivery at a controlled, reproducible dose.
Cannabis inhalation products and methods of production thereof
A proprietary homogeneous cannabinoid formulation comprising cannabinoids uniformly coated onto solid carrier particles to enable controlled vaporization and inhalation. The standardized particulate composition is designed to provide consistent cannabinoid delivery, offering a versatile platform for next-generation inhalable cannabinoid products.
Inventors Aharon M. Eyal, Noa Raz
A multi-user medical cannabis dispenser
A dispenser designed to deliver cannabis compositions to multiple users. The device includes a control unit programmed to deliver a specified cannabis composition at a specific dose to each individual user.
Inventors Noa Raz, Aharon M. Eyal, Yuri Shadurin, Meir Ariel, Itai Rogel, Carmi Raz
Veterinary applications
Cannabinoid science applied beyond human health.
A method of treating bees by administering cannabinoids
Granted in Europe, the United States and Canada as “Veterinary composition and methods for production and use”
A proprietary veterinary cannabinoid formulation for improving honeybee health and colony performance. The composition uses cannabinoids and other cannabis-derived compounds to enhance colony resilience, support immune function, improve resistance to diseases and pests, and increase pollination efficiency and honey production.
Inventors Aharon M. Eyal, Yuval Lin, Netta Lin Cohen, Meir Ariel
All patents listed are granted and are held by Bazelet Group companies. Each entry links to the corresponding public record. Patent numbers, grant dates and claim scope vary by jurisdiction; the descriptions above are summaries provided for general information and do not define the scope of the claims. For licensing, partnership or freedom-to-operate enquiries, please contact us.
